Oxaliplatin-Induced Lhermitte’s Sign in Gastric Cancer

Table 1

Comparison between our case and 13 colorectal cancer patients with OLS.

	Gastric cancer	Colon cancer
Number of reported cases	1 (our case)	13
Chemotherapy regimens	XELOX+trastuzumab	FOLFOX () XELOX ()
Age	64	54.5 (28-73)	(average, range)
Gender	Male	46.2% male
Cumulative oxaliplatin dose (mg/m)	1040	1061 (574-2040)	(average, range)
Time to recovery (months)	3	6.5 (2-17)	(average, range)

Average of 10 cases with precise reports of time to recovery (in months).